Koroner Kalp Hastalığından Korunma ve Tedaviye İlişkin Ulusal Kılavuz

Kaynakça

1-	Onat A, Şurdum -Avcı G, Şenocak M, Örnek Ö, Gözükara Y: Plasma lipids and their interrelationship in Turkish adults. J Epidem Comm Hlth 1992; 46: 470-476.
2-	Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA 1993; 269: 3015-23.
3-	Pyörälä K, De Backer G, Graham I, et al: Prevention of coronary heart disease in clinical practice.Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertention.Eur Heart J 1994; 15: 1300-31.
4-	Prevention of coronary heart disease: Scientific background and new clinical guidelines.Recommendations of the International Task Force for prevention of coronary heart disease. Nutr Med Cardiovasc Dis 1992; 2: 113-56.
5-	Scandinavian Simvastatin Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (45). The Lancet 1994; 344: 1383-1389.
6-	Mahley RW, Palaoğlu KA, Atak Z, et al: Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859.
7-	Shepherd J, Cobbe SM, Ford I, et al: Prevention of coronary heart disease in men with hypercholesterolemia. N Eng J Med 1995; 333: 1301-1307.
8-	Pfeffer MA, Braunwald E, Sacks FM, et al: Cholesterol and recurrent events (CARE study). Presented at 45th Ann Sci Session, Am Coll Card, March 26, 1996, Orlando, Fla.